Specialist responsibilities. Arrange comprehensive assessment of the child and be responsible for making the diagnosis and considering alternative diagnoses, co-morbid diagnoses and cautions/ contraindications to treatment. • Initiate treatment with medication. Inform the GP promptly about changes in treatment or dosage, any important adverse events or if other interacting medicines are prescribed/recommended. • Monitor the patient's condition and response to treatment regularly and keep the GP informed. • Provide a comprehensive baseline physical assessment as recommended in the NICE guidelines, and ensure that height, weight, blood pressure, pulse and appetite are monitored at the recommended time intervals. Communicate the results of tests to the GP as soon as possible. • Explain the possible side effects of the drug and interactions to parents • Provide written guidance for parents (at specialist’s discretion). • Be available for back-up advice on any of the above during working hours • Report all suspected adverse drug reactions (in children under 18 years of age), to the Medicines and Healthcare Regulatory Agency (MHRA) via xxx.xxxx.xxx.xx/xxxxxxxxxx • Send a letter and shared care agreement form to the GP to obtain consent to share prescribing and monitoring responsibilities. • Advise GP’s of any dosage adjustments required, when to refer back, and when and how to stop treatment. • Ensure clear arrangements for back up, advice and support. • Prescribe Atomoxetine once notified by the specialist. • Ensure that the treatment is not continued if the patient fails to attend the specialist clinic for over a year. • Check that patient is being monitored as specified in section on specialist responsibility. • Report to and seek advice from the specialist on any aspect of patient care that is of concern to the GP and may affect treatment. • Refer back to the specialist if the patient’s condition deteriorates. • Monitor the patient for side effects and report all suspected adverse drug reactions (in children under 18 years of age), to the specialist and to the MHRA via xxx.xxxx.xxx.xx/xxxxxxxxxx • Stop the treatment if advised by the specialist. • Ask the specialist or GP anything he or she does not understand about the treatment. • Try to put into practice any behavioural or psychological programmes and report back to the specialist about their effectiveness. • Report any adverse effects to the specialist or GP. • Attend agreed review appointments. Attention Deficit Hyperactivity Disor...
Specialist responsibilities. Discuss with the patient options for treatment and the suitability of azathioprine. 2. Discuss the potential benefits and side effects of treatment with the patient.
Specialist responsibilities. Clarify place of drug in patients current therapy Review the patient's condition and monitor response to treatment regularly as outlined in the monitoring requirements below. Undertake cardiac, hepatic and renal monitoring. To report any change in the clinical condition of the patient to the GP and provide advice regarding continuation/discontinuation of Dronedarone. Outline to the GP when therapy may be stopped assuming no improvement is recognised in the patient’s condition. Advise GPs of when to refer back, and when and how to stop treatment. Report adverse events to the CSM. Ensure clear backup arrangements exist for GPs, for advice and support. Give patients the information leaflet and card for Dronedarone and discuss the interaction with grapefruit juice. Reply to request to participate in shared care arrangement as soon as practicable. To prescribe Dronedarone as requested by the Cardiology Consultant/Electrophysiology team Liaise with the hospital Consultant regarding any complications of treatment. Report suspected side effects to the Consultant and MHRA. Report to and seek advice from the Specialist on any aspect of patient care that is of concern to the GP and that may affect treatment. Refer back to the Specialist if the patient’s condition deteriorates. Stop treatment if advised to do so by the Specialist. Read the information provided and give consent for the chosen treatment. Inform Consultant and GP of any other medication they may be taking or start taking during treatment, including over the counter medicines or herbal remedies. Store and handle medication safely. Report to the specialist or GP if he or she does not have a clear understanding of the treatment. Share any concerns in relation to treatment with the Consultant/GP Report any adverse effects to the specialist or GP whilst taking Dronedarone
Specialist responsibilities. The Specialist Care Service will: • Ensure the patient has been given all the required information including any monitoring books and that they have been informed of side-effects, monitoring requirements and obtain written informed consent • Initiate the patient on DMARD and ensure the patient has been stabilised before transfer to primary care. • Ensure that all relevant investigations have been performed and that the patient is stable prior to transfer of the patient back to primary care. • A comprehensive care summary is provided to primary care • Continue to clinically review the patient if appropriate, at least annually. • Advise on dosage alterations where appropriate. • Respond to primary care queries in a timely manner based on the clinical need of the patient, ensuring appropriate documentation is available. The specialist team will respond within clinically appropriate time scales.
Specialist responsibilities. To ensure patient meets eligibility criteria and requirements
Specialist responsibilities. Arrange comprehensive assessment of the child and be responsible for making the diagnosis and considering alternative diagnoses, co-morbid diagnoses and cautions/ contraindications to treatment. • Initiate treatment with stimulants. Prescribe by brand for sustained release preparations. Inform the GP promptly about changes in treatment or dosage, any important adverse events or if other interacting medicines are prescribed/recommended. • Monitor the patient's condition and response to treatment regularly and keep the GP informed. • Provide a comprehensive baseline physical assessment as recommended in the NICE guidelines, and ensure that height, weight, blood pressure, pulse and appetite are monitored at the recommended time intervals using the chart in the appendix. Communicate the results of tests to the GP as soon as possible. • Explain the possible side effects of the drug and interactions to parents. • Provide written guidance for parents (at specialist’s discretion). • Be available for back-up advice on any of the above during working hours. • Report all suspected adverse drug reactions (in children under 18 years of age), to the Medicines and Healthcare Regulatory Agency (MHRA) via xxx.xxxx.xxx.xx/xxxxxxxxxx • Send a letter and shared care agreement form to the GP to obtain consent to share prescribing and monitoring responsibilities. • Advise GP’s of any dosage adjustments required, when to refer back, and when and how to stop treatment. • Ensure clear arrangements for back up, advice and support. ESCA for ADHD- Dexamfetamine Page 3 of 8 Version 1.0 December 2018 • Prescribe Dexamfetamine once notified by the specialist. • Ensure that the treatment is not continued if the patient fails to attend the specialist clinic for over a year. • Check that patient is being monitored as specified in section on specialist responsibility. • Report to and seek advice from the specialist on any aspect of patient care that is of concern to the GP and may affect treatment. • Refer back to the specialist if the patient’s condition deteriorates. • Monitor the patient for side effects and report all suspected adverse drug reactions (in children under 18 years of age), to the specialist and to the MHRA via xxx.xxxx.xxx.xx/xxxxxxxxxx • Stop the treatment if advised by the specialist. • Ask the specialist or GP anything he or she does not understand about the treatment. • Try to put into practice any behavioural or psychological programmes and report back to the speciali...
Specialist responsibilities. Arrange comprehensive assessment of the patient and be responsible for making the diagnosis and considering alternative diagnoses, co-morbid diagnoses and cautions/ contraindications to treatment Seek carer/family views on baseline function. For adults with ADHD, drug treatment should be the first line treatment unless the person would prefer a psychological approach Drug treatment for adults with ADHD should be started only under the guidance of a psychiatrist ,nurse prescriber specialising in ADHD, or other clinical prescriber with training in the diagnosis and management of ADHD Following a decision to start drug treatment in adults with ADHD, methylphenidate should normally be tried first. Atomoxetine or dexamfetamine should be considered in adults unresponsive or intolerant to an adequate trial of methylphenidate (this should usually be about 6 weeks). Caution should be exercised when prescribing dexamfetamine to those likely to be at risk of stimulant misuse or diversion Initiate treatment with methylphenidate. Prescribe by brand for sustained release preparations. Send a letter and the shared care agreement form to the GP to obtain consent to share prescribing and monitoring responsibilities. Inform the GP promptly about changes in treatment or dosage, any important adverse events or if other interacting medicines are prescribed/recommended Monitor the patient's condition and response to treatment regularly and keep the GP informed Provide a comprehensive baseline physical assessment as recommended in the NICE guidelines, and ensure that height, weight, blood pressure, pulse and appetite are monitored at the recommended time intervals. Communicate the results of tests to the GP as soon as possible. Blood pressure and pulse should be monitored 3 monthly. Explain the possible side effects of the drug and interactions to the patient. Provide written guidance for patient (at specialist’s discretion) Be available for back-up advice on any of the above during working hours Report all suspected adverse drug reactions to the Medicines and Healthcare Regulatory Agency (MHRA) via xxx.xxxxxxxxxx.xxx.uk Send a letter and the shared care agreement form to the GP to obtain consent to share prescribing and monitoring responsibilities Advise GP of any dosage adjustments required, when to refer back, and when and how to stop treatment Ensure clear arrangements for back up, advice and support General Practitioner responsibilities Prescribe the recommended drug once n...
Specialist responsibilities. Discuss the benefits and potential side effects with the patient. Provide patient with relevant drug information to enable informed consent to therapy.
Specialist responsibilities. Identify patients requiring methotrexate and counsel patients appropriately. To eliminate any confusion for prescribers and patients, 10mg tablets should not be prescribed.
Specialist responsibilities. Injection equipment Support and patient training
